scholarly journals Challenges and insights of early phase oncology drug development in the Asia-Pacific region

2019 ◽  
Vol 8 (3) ◽  
pp. 26-26
Author(s):  
Herbert H. Loong ◽  
Daniel S. W. Tan ◽  
Toshio Shimizu
Keyword(s):  
Drug Development ◽  
Early Phase ◽  
Asia Pacific ◽  
Pacific Region ◽  
Asia Pacific Region ◽  
Oncology Drug ◽  
Oncology Drug Development

scholarly journals Assessing the risk of spread of COVID-19 to the Asia Pacific region

2020 ◽  
Author(s):  
Freya M. Shearer ◽  
James Walker ◽  
Nefel Tellioglu ◽  
James M. McCaw ◽  
Jodie McVernon ◽  
...  
Keyword(s):  
Early Phase ◽  
Emerging Disease ◽  
Asia Pacific ◽  
Pacific Region ◽  
Asia Pacific Region ◽  
Outbreak Response ◽  
Case Definitions ◽  
Early Stages ◽  
Travel Restrictions ◽  
Importation Risk

AbstractDuring the early stages of an emerging disease outbreak, governments are required to make critical decisions on how to respond appropriately, despite limited data being available to inform these decisions. Analytical risk assessment is a valuable approach to guide decision-making on travel restrictions and border measures during the early phase of an outbreak, when transmission is primarily contained within a source country. Here we introduce a modular framework for estimating the importation risk of an emerging disease when the direct travel route is restricted and the risk stems from indirect importation via intermediary countries. This was the situation for Australia in February 2020. The framework was specifically developed to assess the importation risk of COVID-19 into Australia during the early stages of the outbreak from late January to mid-February 2020. The dominant importation risk to Australia at the time of analysis was directly from China, as the only country reporting uncontained transmission. However, with travel restrictions from mainland China to Australia imposed from February 1, our framework was designed to consider the importation risk from China into Australia via potential intermediary countries in the Asia Pacific region. The framework was successfully used to contribute to the evidence base for decisions on border measures and case definitions in the Australian context during the early phase of COVID-19 emergence and is adaptable to other contexts for future outbreak response.

scholarly journals Roles of Cancer Registries in Enhancing Oncology Drug Access in the Asia-Pacific Region

2013 ◽  
Vol 14 (4) ◽  
pp. 2159-2165 ◽  
Author(s):  
Swee-Sung Soon ◽  
Hwee-Yong Lim ◽  
Gilberto Lopes ◽  
Jeonghoon Ahn ◽  
Min Hu ◽  
...  
Keyword(s):  
Cancer Registries ◽  
Asia Pacific ◽  
Pacific Region ◽  
Asia Pacific Region ◽  
Drug Access ◽  
Oncology Drug

Review of Counseling in the Asia-Pacific Region.

1995 ◽  
Vol 40 (4) ◽  
pp. 383-384
Author(s):  
Terri Gullickson
Keyword(s):  
Asia Pacific ◽  
Pacific Region ◽  
Asia Pacific Region
Sign in / Sign up

Export Citation Format

Share Document